Olema Pharmaceuticals (OLMA) Other Working Capital Changes (2020 - 2026)

Olema Pharmaceuticals (OLMA) has reported Other Working Capital Changes for 5 consecutive years, with -$313000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 1.29% year-over-year to -$313000.0; the TTM figure through Mar 2026 stood at -$1.2 million (down 3.06% YoY), while the FY2025 annual figure was -$1.2 million, down 7.06% from the prior year.
• Other Working Capital Changes steadied at -$313000.0 in Q1 2026 per OLMA's latest filing, from -$313000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $4.5 million in Q4 2025 and bottomed at -$2.6 million in Q1 2026.
• Historically, Other Working Capital Changes has averaged $265588.2 across 5 years, with a median of -$30000.0 in 2024.
• Annual changes were most pronounced in 2024 — Other Working Capital Changes increased 20.25% — and 2025, when it retreated 18.85%.
• Olema Pharmaceuticals' Other Working Capital Changes stood at -$322000.0 in 2022, then gained by 18.32% to -$263000.0 in 2023, then decreased by 15.97% to -$305000.0 in 2024, then dropped by 2.62% to -$313000.0 in 2025, then changed by 0.0% to -$313000.0 in 2026.
• Business Quant data shows OLMA's Other Working Capital Changes at -$313000.0 in Q1 2026, -$313000.0 in Q4 2025, and -$311000.0 in Q3 2025.